Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 369

    1.

    Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes.

    Garg SK, Schwartz S, Edelman SV.

    Diabetes Care. 2004 Mar;27(3):734-8.PMID: 14988294 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.

    Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L.

    Diabetes Care. 2006 Jan;29(1):44-50.PMID: 16373894 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system.

    Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J.

    Diabetes Technol Ther. 2004 Apr;6(2):105-13.PMID: 15117576 [PubMed - indexed for MEDLINE]Related articles

    4.

    Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.

    Tanenberg R, Bode B, Lane W, Levetan C, Mestman J, Harmel AP, Tobian J, Gross T, Mastrototaro J.

    Mayo Clin Proc. 2004 Dec;79(12):1521-6.PMID: 15595336 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

    Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

    Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

    6.

    Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.

    Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA.

    Diabetes Technol Ther. 2008 Oct;10(5):377-83.PMID: 18715214 [PubMed - indexed for MEDLINE]Related articles

    7.

    What is hypoglycemia in patients with well-controlled type 1 diabetes treated by subcutaneous insulin pump with use of the continuous glucose monitoring system?

    Larsen J, Ford T, Lyden E, Colling C, Mack-Shipman L, Lane J.

    Endocr Pract. 2004 Jul-Aug;10(4):324-9.PMID: 15760775 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.

    Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J.

    Clin Ther. 2004 May;26(5):724-36.PMID: 15220016 [PubMed - indexed for MEDLINE]Related articles

    9.

    Use of short-term real-time continuous glucose monitoring in type 1 diabetes patients on continuous intraperitoneal insulin infusion: a feasibility study.

    Logtenberg SJ, Kleefstra N, Groenier KH, Gans RO, Bilo HJ.

    Diabetes Technol Ther. 2009 May;11(5):293-9.PMID: 19425877 [PubMed - indexed for MEDLINE]Related articles

    10.

    Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.

    Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK.

    Diabetes Technol Ther. 2005 Aug;7(4):587-96.PMID: 16120030 [PubMed - indexed for MEDLINE]Related articles

    12.

    Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.

    Heptulla RA, Allen HF, Gross TM, Reiter EO.

    Pediatr Diabetes. 2004 Mar;5(1):10-5.PMID: 15043684 [PubMed - indexed for MEDLINE]Related articles

    13.

    Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study.

    Bode BW, Gross TM, Thornton KR, Mastrototaro JJ.

    Diabetes Res Clin Pract. 1999 Dec;46(3):183-90. Erratum in: Diabetes Res Clin Pract 2000 Mar;47(3):225. PMID: 10624783 [PubMed - indexed for MEDLINE]Related articles

    14.

    Continuous glucose monitoring and the reality of metabolic control in preschool children with type 1 diabetes.

    Jeha GS, Karaviti LP, Anderson B, Smith EO, Donaldson S, McGirk TS, Haymond MW.

    Diabetes Care. 2004 Dec;27(12):2881-6.PMID: 15562201 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs.

    Guerci B, Floriot M, Böhme P, Durain D, Benichou M, Jellimann S, Drouin P.

    Diabetes Care. 2003 Mar;26(3):582-9.PMID: 12610005 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.

    Peyrot M, Rubin RR.

    Diabetes Technol Ther. 2009 Jan;11(1):57-62.PMID: 19132857 [PubMed - indexed for MEDLINE]Related articles

    19.

    The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes.

    Mastrototaro J, Shin J, Marcus A, Sulur G; STAR 1 Clinical Trial Investigators.

    Diabetes Technol Ther. 2008 Oct;10(5):385-90.PMID: 18715215 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data